Log in
TSE:ACB

Aurora Cannabis Stock Forecast, Price & News

C$6.13
-0.23 (-3.62 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
C$6.06
Now: C$6.13
C$6.40
50-Day Range
C$5.32
MA: C$7.65
C$11.83
52-Week Range
C$5.18
Now: C$6.13
C$61.80
Volume2.07 million shs
Average Volume1.66 million shs
Market CapitalizationC$744.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More
Aurora Cannabis logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-3625207
Employees967

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$278.91 million
Cash FlowC$1.39 per share
Book ValueC$18.67 per share

Profitability

Miscellaneous

Market CapC$744.97 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
C$6.13
-0.23 (-3.62 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aurora Cannabis (TSE:ACB) Frequently Asked Questions

How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACB shares have increased by 423.9% and is now trading at C$6.13.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Aurora Cannabis?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aurora Cannabis
.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc (TSE:ACB) released its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.01). The firm had revenue of $5.18 million for the quarter, compared to the consensus estimate of $7.44 million.
View Aurora Cannabis' earnings history
.

What price target have analysts set for ACB?

8 Wall Street analysts have issued 12 month price targets for Aurora Cannabis' shares. Their forecasts range from C$4.75 to C$12.00. On average, they anticipate Aurora Cannabis' stock price to reach C$9.53 in the next year. This suggests a possible upside of 55.4% from the stock's current price.
View analysts' price targets for Aurora Cannabis
.

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 54)
  • Mr. Terry Booth, Founder, CEO & Director (Age 54)
  • Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

How do I buy shares of Aurora Cannabis?

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately C$6.13.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of C$744.97 million and generates C$278.91 million in revenue each year. Aurora Cannabis employs 967 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.